Rare renal disorders are the fifth most prominent reason behind the cause of end-stage kidney disease (ESKD), ultimately leading to kidney failure, and damage to other tissues. Among such rare kidney diseases, one is complement 3 glomerulopathy (C3G). Albeit rare, the total diagnosed C3G prevalent population in the 7MM (the US, EU5, and Japan) was estimated to be 8,175 in 2017, estimated DelveInsight. The condition is known to affect people of all ages; however, C3G disproportionately affects children and young adults.
Complement 3 glomerulopathy is a rare, chronic renal disease. The primary reason behind the condition is the change in the filtering mechanism...
